| Mutation in blood coagulation factor V associated with resistance to activated protein C RM Bertina, BPC Koeleman, T Koster, FR Rosendaal, RJ Dirven, ... Nature 369 (6475), 64-67, 1994 | 5445 | 1994 |
| Incidence of venous thromboembolism in families with inherited thrombophilia P Simioni, BJ Sanson, P Prandoni, D Tormene, PW Friederich, B Girolami, ... Thrombosis and haemostasis 81 (02), 198-202, 1999 | 448 | 1999 |
| Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism S Eichinger, A Stümpflen, M Hirschl, C Bialonczyk, K Herkner, M Stain, ... Thrombosis and haemostasis 80 (10), 566-569, 1998 | 337 | 1998 |
| Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent JC Gris, I Quéré, F Monpeyrou, E Mercier, S Ripart-Neveu, ML Tailland, ... Thrombosis and haemostasis 81 (06), 891-899, 1999 | 301 | 1999 |
| Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis LAJ Kluijtmans, M Den Heijer, PH Reitsma, SG Heil, HJ Blom, ... Thrombosis and haemostasis 79 (02), 254-258, 1998 | 206 | 1998 |
| Recurrent venous thrombosis and markers of inflammation BE Van Aken, M Den Heijer, GMJ Bos, SJH Van Deventer, PH Reitsma Thrombosis and haemostasis 83 (04), 536-539, 2000 | 191 | 2000 |
| The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene S Eichinger, E Minar, M Hirschl, C Bialonczyk, M Stain, C Mannhalter, ... Thrombosis and haemostasis 81 (01), 14-17, 1999 | 189 | 1999 |
| Endothelial protein C receptor CT Esmon, J Xu, J Gu, D Qu, Z Laszik, G Ferrell, DJ Stearns-Kurosawa, ... Thrombosis and haemostasis 82 (08), 251-258, 1999 | 183 | 1999 |
| Coexistence of factor V Leiden and factor II A20210 mutations and recurrent venous thromboembolism M Margaglione, G D’Andrea, D Colaizzo, G Cappucci, A del Popolo, ... Thrombosis and haemostasis 82 (12), 1583-1587, 1999 | 165 | 1999 |
| Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test J Curvers, MCLGD Thomassen, J Rimmer, K Hamulyak, J van der Meer, ... Thrombosis and haemostasis 88 (07), 5-11, 2002 | 132 | 2002 |
| Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis MBAJ KeiJzer, M Den Heijer, HJ Blom, GMJ Bos, HPJ Willems, ... Thrombosis and haemostasis 88 (11), 723-728, 2002 | 132 | 2002 |
| Tumor thickness versus depth of invasion–Analysis of the 8th edition American Joint Committee on Cancer Staging for oral cancer R Dirven, A Ebrahimi, N Moeckelmann, CE Palme, R Gupta, J Clark Oral oncology 74, 30-33, 2017 | 130 | 2017 |
| VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease J Eikenboom, AB Federici, RJ Dirven, G Castaman, F Rodeghiero, ... Blood, The Journal of the American Society of Hematology 121 (12), 2336-2339, 2013 | 121 | 2013 |
| The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis MCH de Visser, JF Guasch, PW Kamphuisen, HL Vos, FR Rosendaal, ... Thrombosis and haemostasis 83 (04), 577-582, 2000 | 121 | 2000 |
| Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma JL Vos, JBW Elbers, O Krijgsman, JJH Traets, X Qiao, AM van der Leun, ... Nature communications 12 (1), 7348, 2021 | 118 | 2021 |
| Factor XI and protection of the fibrin clot against lysis–a role for the intrinsic pathway of coagulation in fibrinolysis BN Bouma, PAK von dem Borne, JCM Meijers Thrombosis and haemostasis 80 (07), 24-27, 1998 | 113 | 1998 |
| The assessment of pharyngocutaneous fistula rate in patients treated primarily with definitive radiotherapy followed by salvage surgery of the larynx and hypopharynx R Dirven, BD Swinson, K Gao, JR Clark The Laryngoscope 119 (9), 1691-1695, 2009 | 108 | 2009 |
| Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols) C Mauz-Körholz, R Junker, U Göbel, U Nowak-Göttl Thrombosis and haemostasis 83 (06), 840-843, 2000 | 108 | 2000 |
| Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration AM Gori, G Pepe, M Attanasio, M Falciani, R Abbate, D Prisco, S Fedi, ... Thrombosis and haemostasis 81 (04), 589-593, 1999 | 101 | 1999 |
| Expression of tissue factor and tissue factor pathway inhibitor in monocytes in response to bacterial lipopolysaccharide and phorbolester CPE Van der Logt, RJ Dirven, PH Reitsma, RM Bertina Blood coagulation & fibrinolysis 5 (2), 211-220, 1994 | 100 | 1994 |
